000 01289 a2200337 4500
005 20250517032157.0
264 0 _c20160915
008 201609s 0 0 eng d
022 _a1537-4513
024 7 _a10.1097/CJI.0000000000000077
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRanganath, Harsha A
245 0 0 _aAdministration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma.
_h[electronic resource]
260 _bJournal of immunotherapy (Hagerstown, Md. : 1997)
_cJun 2015
300 _a211 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCTLA-4 Antigen
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIpilimumab
650 0 4 _aLiver Transplantation
_xadverse effects
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aTreatment Outcome
700 1 _aPanella, Timothy J
773 0 _tJournal of immunotherapy (Hagerstown, Md. : 1997)
_gvol. 38
_gno. 5
_gp. 211
856 4 0 _uhttps://doi.org/10.1097/CJI.0000000000000077
_zAvailable from publisher's website
999 _c24888973
_d24888973